Sep 19 2005
The plans for a monitoring study on patients being treated with Pentosan Polysulphate (PPS) for CJD and variant CJD have received a favourable opinion from the Eastern Multi-Centre Research Ethics Committee. This follows a provisional opinion from the committee in August.
Consultant neurologist Professor Ian Bone from the Southern General Hospital in Glasgow will now lead the study, which will gather clinical information to help evaluate the potential of PPS as a treatment for CJD.
MRC announced that it would set up a monitoring study of PPS in March 2005. The protocol for the study has been developed following consultation with the families of patients being treated with PPS.
http://www.mrc.ac.uk